Autolus Therapeutics PLC To Discuss Four Clinical Data Updates at the European Hematology Association Congress Call Transcript
Good day, and welcome to the Autolus Therapeutics EHA Investor Call. (Operator Instructions) As a reminder, this call is being recorded. I would now like to turn the call over to CEO, Christian Itin. You may begin.
Thank you, Michelle, and good morning or good afternoon, everyone, and thank you for joining us to take part in today's call to discuss the data presented at the European Hematology Association Congress that has recently been held in Vienna.
Joining us today, we're extremely pleased to welcome Dr. Steven Horwitz from the Department of Medicine, Lymphoma Service at Memorial Sloan Kettering Cancer Center and a Professor of Medicine at Weill Cornell Medical College, Cornell University; and Dr. Kate Cwynarski, Chair of the U.K. T cell Lymphoma Group and Consultant Hematologist, University College London Hospital; Dr. Martin Pule, our Chief Scientific Officer; and Dr. Edgar Braendle, our Chief Development Officer, will also participate in this call.
Before we begin, I
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
